Reckitt Benckiser Group plc (RBGLY)

Market Cap	46.60B
Revenue (ttm)	17.74B
Net Income (ttm)	1.79B
Shares Out	n/a
EPS (ttm)	2.54
PE Ratio	26.10
Forward PE	14.74
Dividend	0.50 (3.60%)
Ex-Dividend Date	Apr 11, 2025

Volume	101,495
Average Volume	406,491
Open	13.95
Previous Close	13.85
Day's Range	13.94 - 14.01
52-Week Range	10.43 - 14.15
Beta	0.10
RSI	62.37
Earnings Date	Jul 24, 2025

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol bran...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1819
• Employees: 37,900
• Stock Exchange: OTCMKTS
• Ticker Symbol: RBGLY

Financial Performance

In 2024, Reckitt Benckiser Group's revenue was 14.17 billion, a decrease of -3.00% compared to the previous year's 14.61 billion. Earnings were 1.43 billion, a decrease of -13.21%.

Financial numbers in GBP